Biotech · Public company · Wayne, PA, US

Aclaris Therapeutics, Inc.

Ticker ACRS · SEC CIK 0001557746

Track this companyFree. Adds Aclaris Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials253 recruiting or active

Pipeline programs32From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline32

A-101Phase 3 · Common WartClinicalTrials.gov · fetched Nov 12, 2026
ActivePhase 3 · Common WartClinicalTrials.gov · fetched Nov 12, 2026
VehiclePhase 3 · Common WartClinicalTrials.gov · fetched Nov 12, 2026
A-101Phase 2 · Seborrheic KeratosisClinicalTrials.gov · fetched Nov 12, 2026
A-101 Topical Solution 40%Phase 2 · Dermatosis Papulosa NigraClinicalTrials.gov · fetched Nov 12, 2026
ATI 502 0.46% Topical SolutionPhase 2 · Alopecia AreataClinicalTrials.gov · fetched Nov 12, 2026
ATI-045Phase 2 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
ATI-1777Phase 2 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
ATI-1777 0.5% w/wPhase 2 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
ATI-1777 1.0% w/wPhase 2 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
ATI-1777 2.0% w/wPhase 2 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
ATI-2138Phase 2 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
ATI-450Phase 2 · Cryopyrin-Associated Periodic SyndromeClinicalTrials.gov · fetched Nov 12, 2026
ATI-450Phase 2 · Hidradenitis SuppurativaClinicalTrials.gov · fetched Nov 12, 2026
ATI-450Phase 2 · Psoriatic ArthritisClinicalTrials.gov · fetched Nov 12, 2026
ATI-450Phase 2 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
ATI-450 20 mg oral tablet BIDPhase 2 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
ATI-450 50 mg oral tablet BIDPhase 2 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
ATI-50002Phase 2 · Alopecia Universalis (AU)ClinicalTrials.gov · fetched Nov 12, 2026
ATI-50002Phase 2 · Androgenetic AlopeciaClinicalTrials.gov · fetched Nov 12, 2026
ATI-50002Phase 2 · Alopecia AreataClinicalTrials.gov · fetched Nov 12, 2026
ATI-50002 high dosePhase 2 · Alopecia AreataClinicalTrials.gov · fetched Nov 12, 2026
ATI-50002 low dosePhase 2 · Alopecia AreataClinicalTrials.gov · fetched Nov 12, 2026
ATI-50002 topical solutionPhase 2 · VitiligoClinicalTrials.gov · fetched Nov 12, 2026
ATI-501 400mg BID (Low dose)Phase 2 · AlopeciaClinicalTrials.gov · fetched Nov 12, 2026
ATI-501 600mg BID (Mid dose)Phase 2 · AlopeciaClinicalTrials.gov · fetched Nov 12, 2026
ATI-501 800mg BID (High dose)Phase 2 · AlopeciaClinicalTrials.gov · fetched Nov 12, 2026
ATI-502Phase 2 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
MethotrexatePhase 2 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
VehiclePhase 2 · Alopecia Universalis (AU)ClinicalTrials.gov · fetched Nov 12, 2026
VehiclePhase 2 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
A-101 Topical SolutionSeborrheic KeratosisClinicalTrials.gov · fetched Nov 12, 2026

Clinical trials25

MK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal AdenocarcinomaPHASE1 · RECRUITING · started Jun 13, 2025ClinicalTrials.gov NCT06648434 · fetched Nov 12, 2026
ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic DermatitisPHASE2 · ACTIVE_NOT_RECRUITING · started May 30, 2025ClinicalTrials.gov NCT07011706 · fetched Nov 12, 2026
Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone MetastasisPHASE1_PHASE2 · RECRUITING · started Jan 30, 2025ClinicalTrials.gov NCT06374459 · fetched Nov 12, 2026
Study of ATI-2138 in Adult Participants With Moderate to Severe Atopic DermatitisPHASE2 · COMPLETED · started Aug 19, 2024ClinicalTrials.gov NCT06585202 · fetched Nov 12, 2026
Study of ATI-450 vs Placebo in Patients With Moderate to Severe Psoriatic ArthritisPHASE2 · TERMINATED · started Jul 12, 2022ClinicalTrials.gov NCT05511519 · fetched Nov 12, 2026
Study of ATI-1777 in Patients 12 to 65 Years Old With Mild to Severe Atopic DermatitisPHASE2 · COMPLETED · started May 11, 2022ClinicalTrials.gov NCT05432596 · fetched Nov 12, 2026
ATI-450 Plus Methotrexate (MTX) Versus Placebo Plus MTX in Participants With Moderate to Severe Active Rheumatoid Arthritis (RA)PHASE2 · COMPLETED · started Feb 1, 2022ClinicalTrials.gov NCT05279417 · fetched Nov 12, 2026
ATI-450 vs Placebo in Participants With Moderate to Severe Hidradenitis Suppurativa (HS)PHASE2 · COMPLETED · started Dec 29, 2021ClinicalTrials.gov NCT05216224 · fetched Nov 12, 2026
Study of ATI-450 in Patients With Cryopyrin-Associated Periodic Syndrome (CAPS)PHASE2 · TERMINATED · started Oct 23, 2020ClinicalTrials.gov NCT04524858 · fetched Nov 12, 2026
Study of ATI-1777 in Adult Patients With Moderate or Severe Atopic DermatitisPHASE2 · COMPLETED · started Sep 30, 2020ClinicalTrials.gov NCT04598269 · fetched Nov 12, 2026
Study of ATI-450 Plus Methotrexate (MTX) vs MTX Alone in Patients With Moderate to Severe RAPHASE2 · COMPLETED · started Mar 16, 2020ClinicalTrials.gov NCT04247815 · fetched Nov 12, 2026
Safety Study of A-101 Topical Solution for the Treatment of Common WartsPHASE3 · COMPLETED · started Feb 7, 2019ClinicalTrials.gov NCT03812510 · fetched Nov 12, 2026
ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT)PHASE2 · TERMINATED · started Jan 15, 2019ClinicalTrials.gov NCT03759340 · fetched Nov 12, 2026
Study of A-101 Topical Solution for the Treatment of Common WartsPHASE3 · COMPLETED · started Sep 17, 2018ClinicalTrials.gov NCT03687372 · fetched Nov 12, 2026
A Study of A-101 Topical Solution for the Treatment of Common WartsPHASE3 · COMPLETED · started Sep 13, 2018ClinicalTrials.gov NCT03691831 · fetched Nov 12, 2026
A Study of ATI-502 Topical Solution for the Treatment of Atopic DermatitisPHASE2 · COMPLETED · started Jul 10, 2018ClinicalTrials.gov NCT03585296 · fetched Nov 12, 2026
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia TotalisPHASE2 · COMPLETED · started Jun 11, 2018ClinicalTrials.gov NCT03594227 · fetched Nov 12, 2026
Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia AreataPHASE2 · COMPLETED · started Apr 11, 2018ClinicalTrials.gov NCT03551821 · fetched Nov 12, 2026
A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical SolutionPHASE2 · COMPLETED · started Mar 22, 2018ClinicalTrials.gov NCT03495817 · fetched Nov 12, 2026
An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic KeratosesPHASE4 · COMPLETED · started Mar 21, 2018ClinicalTrials.gov NCT03487588 · fetched Nov 12, 2026
A Study of ATI-50002 Topical Solution for the Treatment of VitiligoPHASE2 · COMPLETED · started Mar 19, 2018ClinicalTrials.gov NCT03468855 · fetched Nov 12, 2026
Safety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT)PHASE2 · COMPLETED · started Dec 14, 2017ClinicalTrials.gov NCT03315689 · fetched Nov 12, 2026
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia AreataPHASE2 · TERMINATED · started Nov 29, 2017ClinicalTrials.gov NCT03354637 · fetched Nov 12, 2026
A Study of A-101 Topical Solution in Subjects With Dermatosis Papulosa NigraPHASE2 · COMPLETED · started Jun 26, 2017ClinicalTrials.gov NCT03224598 · fetched Nov 12, 2026
Study of A-101 for the Treatment of Seborrheic KeratosisPHASE2 · COMPLETED · started Oct 1, 2014ClinicalTrials.gov NCT02260180 · fetched Nov 12, 2026

SEC filings12

10-Q · 10-QSEC EDGAR · filed Nov 5, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Nov 5, 2026 · fetched Nov 12, 2026
8-K · FORM 8-KSEC EDGAR · filed Oct 27, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Oct 27, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
10-Q · 10-QSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Jun 4, 2026 · fetched Nov 12, 2026
10-Q · 10-QSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Apr 28, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Mar 11, 2026 · fetched Nov 12, 2026